Project Grant R01AI201283
Award Date 8/14/26
Completion Date 7/31/31
Dollars Obligated $837K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New York, NY 10032, USA
Similar Awards
- The National Institute of Allergy and Infectious Diseases awarded The Regents of the University of California, San Francisco $787,837 on April 10, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop and apply computational tools for assessing the risk that diseases with episodic transmission become established in the general population. The project will combine statistical inference with simulation approaches to extend methods for inference using branching...
- Federal Project Grant Award Summary The Trustees of Columbia University in the City of New York, Health Sciences Division, received a $2,056,250 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through August 31, 2029. This four-year award funds the development of novel computational tools and methodologies for early detection and inference of emerging...
- The National Institute of Allergy and Infectious Diseases awarded the University of Virginia $668,128 on August 12, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop artificial intelligence and machine learning methods for hospital-acquired infection risk prediction, surveillance, and infection control. The recipient will design a multi-disciplinary approach combining deep learning, agent-based modeling, human factors, and systems science to address gaps...
- The National Institute of Allergy and Infectious Diseases awarded The Trustees of Columbia University in the City of New York $194,160 on April 2, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to support a mentored career development project on neutralizing antibody pressure and SARS-CoV-2 viral evolution. The project develops an in vitro model to predict where mutations will appear in SARS-CoV-2 and leverages that knowledge to design updated vaccines. The...
- The National Institute of Allergy and Infectious Diseases awarded Albert Einstein College of Medicine $252,000 on August 3, 2026, to develop community-led, accountable, and ethical recommendations for artificial intelligence use in HIV implementation science research under the Allergy and Infectious Diseases Research program (CFDA 93.855). The recipient will employ community-engaged methods to co-develop CARE-AI (Community-led Accountable Responsible and Ethical recommendations for AI)...
- The National Institute of Allergy and Infectious Diseases awarded The Trustees of Columbia University in the City of New York $452,375 on June 16, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to identify transcription factors that promote pulmonary infection by opportunistic pathogens. The recipient will conduct research to determine how the transcription factor RpoN responds to environmental signals in Pseudomonas aeruginosa and Klebsiella pneumoniae, and how...
- The National Institute of Allergy and Infectious Diseases awarded The Trustees of Columbia University in the City of New York $3,144,408 on February 6, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to investigate regulatory T cell memory in human tissues. The award funds research to characterize the role, identity, and function of human regulatory T cells (Tregs) across diverse tissues and their interactions with immune and structural cells. The project will...
- The National Institute of Allergy and Infectious Diseases awarded New York University $836,484 on May 19, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop vectored immunoprophylaxis using ACE2 receptor decoys to prevent and treat SARS-CoV-2 infection. The project will develop and test high-affinity ACE2 receptor decoys—composed of the extracellular domain of ACE2 fused to a truncated immunoglobulin heavy-chain Fc region—delivered via adeno-associated...
- The National Institute of Allergy and Infectious Diseases awarded The Trustees of Columbia University in the City of New York $821,367 on May 1, 2026, to support systematic functional variant-to-pathway and phenotype evaluation in genetic disorders of the immune system. The recipient will conduct functional variant mapping of rare and common genetic variants in immune system diseases using a CRISPR-base editing framework in primary human T cells. The work focuses on clarifying variants of...
- The National Institute of Allergy and Infectious Diseases awarded Sloan-Kettering Institute for Cancer Research $3,519,992 on March 1, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop computational and microbiome-based strategies for predicting and preventing gut-borne bloodstream infections in immunocompromised patients. The project will develop three integrated tools: computational models to forecast infection risk based on microbiome dynamics,...